Score Overview
Explore the 2021 public Archive ranking โ
Where Omnicell Inc has ranked, year by year
Showing 1 year ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- OMCL
2007: 9.4% ยท 2021: 72.6% ยท free through 2021 ยท longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-29 | $ 34.31 | โ |
1 Year2025-09-29 | $ 30.34 | 13.09% |
5 Years2021-09-29 | $ 149.22 | -77.01% |
10 Years2016-09-29 | $ 37.43 | -8.34% |
20 Years2006-09-29 | $ 17.89 | 91.78% |
All Time2001-08-07 | $ 9.51 | 260.78% |
| Period | Last Price2026-09-29 | 1 Year2025-09-29 | 5 Years2021-09-29 | 10 Years2016-09-29 | 20 Years2006-09-29 | All Time2001-08-07 |
|---|---|---|---|---|---|---|
| Price | $ 34.31 | $ 30.34 | $ 149.22 | $ 37.43 | $ 17.89 | $ 9.51 |
| Return | โ | 13.09% | -77.01% | -8.34% | 91.78% | 260.78% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 1.24B | $ 39M | $ 292M |
| 2025 | $ 1.18B | $ 2M | $ 196M |
| 2024 | $ 1.11B | $ 12M | $ 381M |
| 2023 | $ 1.14B | -$ 20M | $ 467M |
| 2022 | $ 1.29B | $ 5M | $ 341M |
| 2021 | $ 1.13B | $ 77M | $ 359M |
| 2020 | $ 892M | $ 32M | $ 496M |
| 2019 | $ 897M | $ 61M | $ 136M |
| 2018 | $ 787M | $ 37M | $ 67M |
| 2017 | $ 716M | $ 20M | $ 32M |
| 2016 | $ 692M | $ 603K | $ 54M |
| 2015 | $ 484M | $ 30M | $ 82M |
| 2014 | $ 440M | $ 30M | $ 125M |
| 2013 | $ 380M | $ 23M | $ 104M |
| 2012 | $ 314M | $ 16M | $ 62M |
| 2011 | $ 245M | $ 10M | $ 199M |
| 2010 | $ 222M | $ 4M | $ 183M |
| 2009 | $ 213M | $ 444K | $ 169M |
| 2008 | $ 251M | $ 12M | $ 120M |
| 2007 | $ 213M | $ 43M | $ 169M |
| 2006 | $ 154M | $ 10M | $ 60M |
| 2005 | $ 121M | -$ 2M | $ 29M |
| 2004 | $ 123M | $ 10M | $ 30M |
| 2003 | $ 102M | $ 7M | $ 33M |
| 2002 | $ 87M | -$ 5M | $ 21M |
| IPO2001 | $ 86M | -$ 1M | $ 23M |

Omnicell Inc fundamental performance
Between 2015 and 2025, revenue grew from $ 484M to $ 1.18B and net income declined from $ 30M to $ 2M. Revenue increased in 7 of those 10 years; net income in 6.
Across Omnicell Inc's full reported history, from 2001 to 2025, revenue grew from $ 86M to $ 1.18B and net income went from -$ 1M to $ 2M. Revenue increased in 80% of the years measured; net income in 64%.
Omnicell Inc currently holds a 20-year HDB Score of 5.5 out of 10. How the HDB Score is calculated.
Membership
Continue OMCLโs history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
Explore other companies
Neogen CorporationNEOGยท revenue grew in 90% of years
Fresenius Medical Care CorporationFMSยท revenue grew in 80% of years
Innoviva IncINVAยท revenue grew in 75% of years
Ligand Pharmaceuticals IncorporatedLGNDยท revenue grew in 75% of years
Bristol-Myers Squibb CompanyBMYยท revenue grew in 65% of years